|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/00 |
| (11) | Patento numeris | 3035956 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14837376.4 |
| Europos patento paraiškos padavimo data | 2014-08-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-06-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/051793 |
| Data | 2014-08-20 |
| (87) | Numeris | WO 2015/026894 |
| Data | 2015-02-26 |
| (30) | Numeris | Data | Šalis |
| 201361869528 P | 2013-08-23 | US | |
| 201361907691 P | 2013-11-22 | US | |
| 13198859 | 2013-12-20 | EP |
| (72) |
MOORE, Paul A., US
LI, Jonathan, US
CHEN, Francine Zhifen, US
JOHNSON, Leslie S., US
SHAH, Kalpana, US
BONVINI, Ezio, US
|
| (73) |
MacroGenics, Inc.,
9704 Medical Center Drive, Rockville, MD 20850,
US
|
| (54) | BI-SPECIFIC MONOVALENT DIABODIES THAT ARE CAPABLE OF BINDING TO GPA33 AND CD3, AND USES THEREOF |
| BI-SPECIFIC MONOVALENT DIABODIES THAT ARE CAPABLE OF BINDING TO GPA33 AND CD3, AND USES THEREOF |